Brief: Guided Therapeutics reports Q4 loss $1.32/shr
14/03/2016 20:05
March 14 (Reuters) - Guided Therapeutics Inc GTHPD.OB : * Reports 2015 results with strong uptick in fourth quarter * Q4 revenue $250,000 * Qtrly loss per share $1.32 * Says plan to raise additional capital in the first half of 2016 * Says anticipate orders in the $3.0 million to $5.0 million range for the year * Source text for Eikon urn:newsml:reuters.com:*:nBw1wps3Ba * Further company coverage GTHPD.OB ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Guided Therapeutics
See all newsBrief: Guided Therapeutics Receives $700,000 Purchase Order And Initial Payment From New Chinese Distributor
Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
Brief: Guided Therapeutics Inc Have Applied To List Common Stock On Nasdaq Capital Market
Brief: Guided Therapeutics Says Replaces Convertible Note Facility And Significantly Reduces Dilution